<DOC>
	<DOCNO>NCT00274430</DOCNO>
	<brief_summary>A double-blind placebo control study - To compare effect tadalafil dexamethasone versus placebo Ppa pulmonary edema formation subject susceptible HAPE . - To investigate effect dexamethasone alveolar fluid clearance , assess measurement nasal potential difference , prevention HAPE . - To investigate effect tadalafil dexamethasone versus placebo dynamic CBF autoregulation property development AMS HAPE susceptible subject .</brief_summary>
	<brief_title>Prevention High Altitude Pulmonary Edema</brief_title>
	<detailed_description />
	<mesh_term>Edema</mesh_term>
	<mesh_term>Altitude Sickness</mesh_term>
	<mesh_term>Pulmonary Edema</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>At least one previous episode high altitude pulmonary edema pulmonary arterial hypertension congenital heart disease chronic lung disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2003</verification_date>
</DOC>